Lower toxicity with targeted anticancer agents in phase I trials

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2012年 / 1416卷 / 1期
关键词：
Independent Predictor; Component Variable; National Cancer Institute; Anticancer Agent; Advanced Cancer;
D O I：
10.2165/00128415-201214160-00005
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [1] Association of creatine kinase and skin toxicity in phase I trials of anticancer agents
    Garcia, V. Moreno
    Thavasu, P.
    Codesido, M. Blanco
    Molife, L. R.
    Pedersen, J. Vitfell
    Puglisi, M.
    Basu, B.
    Shah, K.
    Iqbal, J.
    de Bono, J. S.
    Kaye, S. B.
    Banerji, U.
    BRITISH JOURNAL OF CANCER, 2012, 107 (11) : 1797 - 1800
  • [2] Association of creatine kinase and skin toxicity in phase I trials of anticancer agents
    V Moreno Garcia
    P Thavasu
    M Blanco Codesido
    L R Molife
    J Vitfell Pedersen
    M Puglisi
    B Basu
    K Shah
    J Iqbal
    J S de Bono
    S B Kaye
    U Banerji
    British Journal of Cancer, 2012, 107 : 1797 - 1800
  • [3] Creatinine Clearance Is Associated with Toxicity from Molecularly Targeted Agents in Phase I Trials
    Basu, B.
    Vitfell-Pedersen, J.
    Garcia, V. Moreno
    Puglisi, M.
    Tjokrowidjaja, A.
    Shah, K.
    Malvankar, S.
    Anghan, B.
    de Bono, J. S.
    Kaye, S. B.
    Molife, L. R.
    Banerji, U.
    ONCOLOGY, 2012, 83 (04) : 177 - 182
  • [4] Ocular Toxicity of Targeted Anticancer Agents
    Fortes, Blake H.
    Tailor, Prashant D.
    Dalvin, Lauren A.
    DRUGS, 2021, 81 (07) : 771 - 823
  • [5] Ocular Toxicity of Targeted Anticancer Agents
    Blake H. Fortes
    Prashant D. Tailor
    Lauren A. Dalvin
    Drugs, 2021, 81 : 771 - 823
  • [6] Phase I trials of targeted anticancer drugs: a need to refocus
    Ernest C. Borden
    Afshin Dowlati
    Nature Reviews Drug Discovery, 2012, 11 : 889 - 890
  • [7] Learning from toxicity patterns in phase I trials during the era of mechanism targeted agents
    Greystoke, A.
    Ranson, M.
    ANNALS OF ONCOLOGY, 2012, 23 (08) : 1934 - 1936
  • [8] Phase I trials of targeted anticancer drugs: a need to refocus
    Borden, Ernest C.
    Dowlati, Afshin
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (12) : 889 - 890
  • [9] Ethnic, gender, and age disparities and outcome of phase I clinical trials of biologically targeted anticancer agents
    Owonikoko, Taofeek K.
    Lewis, Colleen
    Busari, Adeniyi K.
    Kim, Sungjin
    Chen, Zhengjia
    Lawson, David H.
    Carthon, Bradley C.
    El-Rayes, Bassel F.
    Khuri, Fadlo R.
    Kauh, John
    Harvey, R. Donald
    Ramalingam, Suresh S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11)
  • [10] Multi-institutional phase I trials of anticancer agents
    Dowlati, Afshin
    Manda, Sudhir
    Gibbons, Joseph
    Remick, Scot C.
    Patrick, Lauren
    Fu, Pingfu
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 1926 - 1931
12345